CD4 and neoplasm: Its high expression in LIHC patients promotes immune cell infiltration in the tumor microenvironment characterized by B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and dendritic cells with M2 macrophage significant association for a poor survival prognosis.